Shruti U Gandhy

4PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 05, 2026
FDA Approval Summary: Retifanlimab for the treatment of adult patients with metastatic or inoperable locally recurrent squamous cell carcinoma of the anal canal.

|Jun 08, 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements.

Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti

|Mar 11, 2022
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.

Jason M Redman, Yo-Ting Tsai, Benjamin A Weinberg

|Jun 30, 2020
The immunotherapy revolution in genitourinary malignancies.

Shruti U Gandhy, Ravi A Madan, Jeanny B Aragon-Ching

Pageof 1

Frequent Collaborators

2 joint publications

Steven J Lemery

2 joint publications

Doris Auth

2 joint publications

Sandra J Casak

1 joint publications

R Angelo de Claro